Influence of APOE Genotype on Alzheimer’s Disease CSF Biomarkers in a Spanish Population
Open Access
- 22 March 2016
- journal article
- research article
- Published by Hindawi Limited in BioMed Research International
- Vol. 2016, 1-7
Abstract
Objectives. To evaluate the association between apolipoprotein E (APOE) genotype and cerebrospinal fluid (CSF) levels of Alzheimers disease (AD) biomarkers and to study the influence of APOE genotype on the development of AD in a Spanish population. Material and Methods. The study comprised 29 amnestic mild cognitive impairment (MCI) patients and 27 control subjects. Using ELISA methodology, CSF biomarkers and tau/Aβ ratios were obtained. ANOVA and adjusted odds ratios were calculated. Results. We observed the effect of APOE genotype and age on CSF AD variables. The progression to AD was more clearly influenced by CSF AD variables than by age or APOE status. Conclusions. APOE status influences CSF AD variables. However, the presence of APOE ε4 does not appear to be a deterministic factor for the development of AD, because CSF variables have a greater influence on progression to the disease. These results confirm previous observations and, to our knowledge, are the first published in a Spanish population. Objectives. To evaluate the association between apolipoprotein E (APOE) genotype and cerebrospinal fluid (CSF) levels of Alzheimers disease (AD) biomarkers and to study the influence of APOE genotype on the development of AD in a Spanish population. Material and Methods. The study comprised 29 amnestic mild cognitive impairment (MCI) patients and 27 control subjects. Using ELISA methodology, CSF biomarkers and tau/Aβ ratios were obtained. ANOVA and adjusted odds ratios were calculated. Results. We observed the effect of APOE genotype and age on CSF AD variables. The progression to AD was more clearly influenced by CSF AD variables than by age or APOE status. Conclusions. APOE status influences CSF AD variables. However, the presence of APOE ε4 does not appear to be a deterministic factor for the development of AD, because CSF variables have a greater influence on progression to the disease. These results confirm previous observations and, to our knowledge, are the first published in a Spanish population.Keywords
Funding Information
- Novartis Spain
This publication has 35 references indexed in Scilit:
- Epidemiological and Economic Burden of Alzheimer's Disease: A Systematic Literature Review of Data across Europe and the United States of AmericaJournal of Alzheimer’s Disease, 2014
- Apolipoprotein E Genotype and the Diagnostic Accuracy of Cerebrospinal Fluid Biomarkers for Alzheimer DiseaseJAMA Psychiatry, 2014
- SUCLG2 identified as both a determinator of CSF Aβ1–42 levels and an attenuator of cognitive decline in Alzheimer's diseaseHuman Molecular Genetics, 2014
- Alzheimer Disease Cerebrospinal Fluid Biomarkers Predict Cognitive Decline In Healthy Elderly Over 2 YearsAlzheimer Disease & Associated Disorders, 2014
- The cerebrospinal fluid “Alzheimer profile”: Easily said, but what does it mean?Alzheimer's & Dementia, 2014
- Genetic interaction of PICALM and APOE is associated with brain atrophy and cognitive impairment in Alzheimer's diseaseAlzheimer's & Dementia, 2014
- ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's diseaseNeuroImage: Clinical, 2014
- Integration and relative value of biomarkers for prediction of MCI to AD progression: Spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkersNeuroImage: Clinical, 2014
- Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapyNature Reviews Neurology, 2013
- Biochemical Studies of Poly-T Variants in the Alzheimer's Disease Associated TOMM40 GeneJournal of Alzheimer’s Disease, 2012